Company / Total Assets
MAIA Biotechnology, Inc. Total Assets History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$10.2M
FY2024
5-year range
$7.6M / $12.0M
FY2022-FY2024
Trend
+34.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $12M to $10M over the past 2 years.
Based on SEC 10-K filings.
$10M in FY2024.
Declined from $12M to $10M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, total assets increased 34.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -11.78 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $10.2M | +34.2% |
| FY2023 | $7.6M | -37.1% |
| FY2022 | $12.0M | - |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 24, 2026